Suppr超能文献

The role and prospect of tofacitinib in patients with ulcerative colitis.

作者信息

Lee Jun

机构信息

Department of Internal Medicine, Chosun University College of Medicine, Gwangju, Korea.

出版信息

Intest Res. 2023 Jan;21(1):168-169. doi: 10.5217/ir.2022.00098. Epub 2022 Nov 14.

Abstract
摘要

相似文献

1
The role and prospect of tofacitinib in patients with ulcerative colitis.
Intest Res. 2023 Jan;21(1):168-169. doi: 10.5217/ir.2022.00098. Epub 2022 Nov 14.
2
Tofacitinib Salvage Therapy for Children Hospitalized for Corticosteroid- and Biologic-Refractory Ulcerative Colitis.
J Pediatr Gastroenterol Nutr. 2022 Dec 1;75(6):724-730. doi: 10.1097/MPG.0000000000003616. Epub 2022 Sep 19.
3
Tofacitinib for Rescue Therapy in Acute Severe Ulcerative Colitis: A Real-world Experience.
J Crohns Colitis. 2020 Jul 30;14(7):1026-1028. doi: 10.1093/ecco-jcc/jjaa018.
4
Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis.
N Engl J Med. 2012 Aug 16;367(7):616-24. doi: 10.1056/NEJMoa1112168.
5
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
N Engl J Med. 2017 May 4;376(18):1723-1736. doi: 10.1056/NEJMoa1606910.
6
Perioperative safety of tofacitinib in surgical ulcerative colitis patients.
Colorectal Dis. 2021 Aug;23(8):2085-2090. doi: 10.1111/codi.15702. Epub 2021 May 24.
7
Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry.
Aliment Pharmacol Ther. 2020 May;51(9):880-888. doi: 10.1111/apt.15689. Epub 2020 Apr 1.
8
Efficacy of tofacitinib treatment in ulcerative colitis.
Gastroenterol Hepatol. 2019 Jun-Jul;42(6):403-412. doi: 10.1016/j.gastrohep.2019.03.002. Epub 2019 May 14.
10
Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study.
Clin Gastroenterol Hepatol. 2021 Oct;19(10):2112-2120.e1. doi: 10.1016/j.cgh.2021.05.038. Epub 2021 May 25.

引用本文的文献

本文引用的文献

1
Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis.
Intest Res. 2023 Jan;21(1):61-87. doi: 10.5217/ir.2022.00007. Epub 2022 May 31.
3
Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study.
Intest Res. 2021 Jan;19(1):71-82. doi: 10.5217/ir.2019.09159. Epub 2020 Sep 4.
4
Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis.
Intest Res. 2021 Jul;19(3):323-331. doi: 10.5217/ir.2020.00039. Epub 2020 Aug 18.
6
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
N Engl J Med. 2019 Sep 26;381(13):1201-1214. doi: 10.1056/NEJMoa1900750.
8
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
N Engl J Med. 2017 May 4;376(18):1723-1736. doi: 10.1056/NEJMoa1606910.
9
Vedolizumab as induction and maintenance therapy for ulcerative colitis.
N Engl J Med. 2013 Aug 22;369(8):699-710. doi: 10.1056/NEJMoa1215734.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验